149 related articles for article (PubMed ID: 10871979)
1. The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group.
Flack JM; Yunis C; Preisser J; Holmes CB; Mensah G; McLean B; Saunders E
Arch Intern Med; 2000 Jun; 160(12):1842-7. PubMed ID: 10871979
[TBL] [Abstract][Full Text] [Related]
2. Quinapril for treatment of hypertension in Turkey: dose titration and diuretic combination treatment strategies.
Yener G; Aran S; Bahceci M; Ozdemir K; Gultekin F; Lowe W
Clin Drug Investig; 2007; 27(9):613-22. PubMed ID: 17705570
[TBL] [Abstract][Full Text] [Related]
3. [The Study Group of Quinapril in Arterial Hypertension. The Steering Committee].
Ambrosioni E; Brusca A; Caponnetto S; Condorelli M; Corea L; Dal Palù C; Fogari R; Mameli P; Mancia G; Neri Serneri GG
Minerva Cardioangiol; 1992 Mar; 40(3):85-96. PubMed ID: 1630680
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
Frishman WH; Greenberg S
Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
[TBL] [Abstract][Full Text] [Related]
5. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
Romero R; Castellote E; Ocón J; Wagner B
J Cardiovasc Pharmacol; 1995 Jul; 26(1):114-8. PubMed ID: 7564350
[TBL] [Abstract][Full Text] [Related]
6. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
Larochelle P; Haynes B; Maron N; Dugas S
Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of low-dose, once-daily quinapril as monotherapy for patients with hypertension.
Olvera S; Alcocer L; Novoa G
Clin Ther; 1996; 18(5):864-73. PubMed ID: 8930430
[TBL] [Abstract][Full Text] [Related]
8. Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial.
Mokwe E; Ohmit SE; Nasser SA; Shafi T; Saunders E; Crook E; Dudley A; Flack JM
Hypertension; 2004 Jun; 43(6):1202-7. PubMed ID: 15117912
[TBL] [Abstract][Full Text] [Related]
9. Quinapril: a double-blind, placebo-controlled trial in essential hypertension.
Maclean D
Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581
[TBL] [Abstract][Full Text] [Related]
10. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
Bahena JH; Estrella ME; Muñoz M
Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
[TBL] [Abstract][Full Text] [Related]
11. The management of hypertension in older patients.
Schnaper HW
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S56-61. PubMed ID: 1691408
[TBL] [Abstract][Full Text] [Related]
12. The incidence of first-dose hypotension with quinapril in patients with mild to moderate hypertension.
Maclean D; Maton SM; Bibby AJ; Eminton Z
Br J Clin Pract; 1993; 47(5):234-6. PubMed ID: 8292465
[TBL] [Abstract][Full Text] [Related]
13. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
Ding YA; Chang SM; Chou TC
J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
[TBL] [Abstract][Full Text] [Related]
14. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H
J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540
[TBL] [Abstract][Full Text] [Related]
15. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
Lacourcière Y; Lefebvre J; Provencher P; Poirier L
Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
[TBL] [Abstract][Full Text] [Related]
16. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
17. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group.
Larochelle P
Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779
[TBL] [Abstract][Full Text] [Related]
18. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
[TBL] [Abstract][Full Text] [Related]
19. Assessing the clinical need for short-term conversion from oral to parenteral angiotensin converting enzyme inhibitor therapy in hypertensive patients. A quinapril to quinaprilat placebo-controlled model.
Whelton A; McCormick L; Wombolt D; Goldstein R; Canter D
Eur Heart J; 1997 Jan; 18(1):140-7. PubMed ID: 9049526
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study.
Palatini P; Jung W; Shlyakhto E; Botha J; Bush C; Keefe DL
J Hum Hypertens; 2010 Feb; 24(2):93-103. PubMed ID: 19458624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
